Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies

Karuppasamy, Muthukumar; Mahapatra, Manojkumar; YABANOĞLU ÇİFTÇİ, SAMİYE; UÇAR, GÜLBERK; Sinha, Barij; Basu, Arijit; Mishra, Nibha; Sharon, Ashoke; Kulandaivelu, Umasankar; Jayaprakash, Venkatesan

doi:10.1016/j.bmc.2010.01.043

Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies

Karuppasamy M., Mahapatra M., YABANOĞLU ÇİFTÇİ S., UÇAR G., Sinha B. N., Basu A., ...Daha Fazla

BIOORGANIC & MEDICINAL CHEMISTRY, cilt.18, sa.5, ss.1875-1881, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 5
Basım Tarihi: 2010
Doi Numarası: 10.1016/j.bmc.2010.01.043
Dergi Adı: BIOORGANIC & MEDICINAL CHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1875-1881
Hacettepe Üniversitesi Adresli: Evet

Özet

3,5-Diaryl pyrazolines analogs were synthesized and evaluated for their monoamine oxidase (MAO) inhibitory activity. The compounds were found reversible and selective towards MAO-A with selectivity index in the magnitude of 10(3)-10(5). The docking studies were carried out to gain further structural insights of the binding mode and possible interactions with the active site of MAO-A. Interestingly, the theoretical (K-i) values obtained by molecular docking studies were in congruence with their experimental (K-i) values. (C) 2010 Elsevier Ltd. All rights reserved.